Sanofi gets FDA approval for NovoLog insulin biosimilar
Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...
Hosted on MSN2mon
Novo Nordisk slashes U.S. list prices for insulin meds Tresiba, Fiasp
Novo Nordisk said it will cut the list prices in ... Fiasp's price will be reduced by 75%, making it the same price as NovoLog (insuin aspart), while Tresiba's price will be reduced by 72% ...